Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Mesoblast Ltd

+ Add to Watchlist

LWB:GR

2.677 EUR 0.073 2.65%

As of 04:55:02 ET on 04/17/2015.

Snapshot for Mesoblast Ltd (LWB)

Open: 2.750 Day's Range: 2.677 - 2.750 Volume: 0
Previous Close: 2.750 52wk Range: 2.243 - 3.988 1-Yr Rtn: -16.58%

Stock Chart for LWB

No chart data available.
  • LWB:GR 2.677
  • 1D
  • 1M
  • 1Y
2.750
Interactive LWB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LWB

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -0.2760
Est. PEG Ratio -
Market Cap (M EUR) 909.59
Shares Outstanding (M) 339.78
30 Day Average Volume 21
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LWB

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for LWB

Mesoblast Ltd., is a biotechnology company. The Company develops treatments for orthopaedic conditions, including the commercialisation of adult stem cells to regenerate, repair bone. and cartilage.

Silviu ItescuChief Executive OfficerPaul HodgkinsonChief Financial Officer
James T Ryaby "Jim"VP:Research & Clinical AffairsJohn McMannisExec VP:Manufacturing
More Company Profile & Key Executives for LWB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil